"Neurotoxicity Syndromes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents.
| Descriptor ID |
D020258
|
| MeSH Number(s) |
C10.720 C25.723.705
|
| Concept/Terms |
Neurotoxicity Syndromes- Neurotoxicity Syndromes
- Neurotoxicity Syndrome
- Syndrome, Neurotoxicity
- Syndromes, Neurotoxicity
- Neurotoxin Disorders
- Neurotoxin Disorder
- Neurotoxic Disorders
- Neurotoxic Disorder
- Neurotoxin Diseases
- Neurotoxin Disease
- Poisoning, Nervous System
- Nervous System Poisonings
- Poisonings, Nervous System
- Nervous System Poisoning
Encephalopathy, Toxic- Encephalopathy, Toxic
- Encephalopathies, Toxic
- Toxic Encephalopathies
- Toxic Encephalopathy
Toxic Encephalitis- Toxic Encephalitis
- Encephalitides, Toxic
- Encephalitis, Toxic
- Toxic Encephalitides
|
Below are MeSH descriptors whose meaning is more general than "Neurotoxicity Syndromes".
Below are MeSH descriptors whose meaning is more specific than "Neurotoxicity Syndromes".
This graph shows the total number of publications written about "Neurotoxicity Syndromes" by people in this website by year, and whether "Neurotoxicity Syndromes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 2 | 1 | 3 |
| 2018 | 2 | 0 | 2 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 3 | 0 | 3 |
| 2023 | 1 | 2 | 3 |
| 2024 | 1 | 0 | 1 |
| 2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neurotoxicity Syndromes" by people in Profiles.
-
Prediction of methotrexate neurotoxicity using clinical, sociodemographic, and area-based information in children with acute lymphoblastic leukemia. Oncologist. 2025 Jun 04; 30(6).
-
Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell Lymphoma. Transplant Cell Ther. 2025 Jul; 31(7):419-433.
-
Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia. Pharmacotherapy. 2025 Jan; 45(1):4-11.
-
Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study. Blood Adv. 2023 10 24; 7(20):6055-6065.
-
Ciltacabtagene Autoleucel in Patients With Prior Allogeneic Stem Cell Transplant in the CARTITUDE-1 Study. Clin Lymphoma Myeloma Leuk. 2023 12; 23(12):882-888.
-
Tumor inflammation-associated neurotoxicity. Nat Med. 2023 04; 29(4):803-810.
-
Neuroprotective strategies in anesthesia-induced neurotoxicity. Best Pract Res Clin Anaesthesiol. 2023 Mar; 37(1):52-62.
-
Anesthesia and Developing Brains: Unanswered Questions and Proposed Paths Forward. Anesthesiology. 2022 03 01; 136(3):500-512.
-
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies. Blood Cancer J. 2022 02 24; 12(2):32.
-
UPF1 reduces C9orf72 HRE-induced neurotoxicity in the absence of nonsense-mediated decay dysfunction. Cell Rep. 2021 03 30; 34(13):108925.